References analysis of the Wikipedia article "Sitio de unión" in the Galician version

books.google.com

Kenakin TP (abril de 2016). "Characteristics of Allosterism in Drug Action". En Bowery NG. Allosteric Receptor Modulation in Drug Targeting. CRC Press. p. 26. ISBN 978-1-4200-1618-5.

Bellelli A, Carey J (xaneiro de 2018). "Reversible Ligand Binding". Reversible Ligand Binding: Theory and Experiment. John Wiley & Sons. p. 278. ISBN 978-1-119-23848-5.

doi.org

dx.doi.org

Amos-Binks A, Patulea C, Pitre S, Schoenrock A, Gui Y, Green JR, Golshani A, Dehne F (xuño de 2011). "Binding site prediction for protein-protein interactions and novel motif discovery using re-occurring polypeptide sequences". BMC Bioinformatics 12: 225. PMC 3120708. PMID 21635751. doi:10.1186/1471-2105-12-225.

Nazem F, Ghasemi F, Fassihi A, Mehri Dehnavi A (abril de 2021). "3D U-Net: A Voxel-based method in binding site prediction of protein structure". Journal of Bioinformatics and Computational Biology 19 (1): 1–10. ISSN 1757-6334. PMID 33866960. doi:10.1142/S0219720021500062.

Spitzer R, Cleves AE, Varela R, Jain AN (abril de 2014). "Protein function annotation by local binding site surface similarity". Proteins 82 (4): 679–94. PMC 3949165. PMID 24166661. doi:10.1002/prot.24450.

Bandyopadhyay A, Gao J (outubro de 2016). "Targeting biomolecules with reversible covalent chemistry". Current Opinion in Chemical Biology 34: 110–116. PMC 5107367. PMID 27599186. doi:10.1016/j.cbpa.2016.08.011.

Xu D, Jalal SI, Sledge GW, Meroueh SO (outubro de 2016). "Small-molecule binding sites to explore protein-protein interactions in the cancer proteome". Molecular BioSystems 12 (10): 3067–87. PMC 5030169. PMID 27452673. doi:10.1039/c6mb00231e.

Wilson K (marzo de 2010). Principles and Techniques of Biochemistry and Molecular Biology. Cambridge University Press. pp. 581–624. ISBN 9780511841477. doi:10.1017/cbo9780511841477.016.

Kumar AP, Lukman S (2018-06-06). "Allosteric binding sites in Rab11 for potential drug candidates". PLOS ONE 13 (6): e0198632. Bibcode:2018PLoSO..1398632K. PMC 5991966. PMID 29874286. doi:10.1371/journal.pone.0198632.

Azzaroni O, Szleifer I (2017-12-04). Polymer and Biopolymer Brushes. ISBN 978-1-119-45501-1. doi:10.1002/9781119455042.

Clarke KG (2013). Bioprocess engineering. Woodhead Publishing. pp. 79–84. ISBN 978-1-78242-167-2. doi:10.1533/9781782421689.

Wilson K (marzo de 2010). "Enzymes". En Wilson K, Walker J. Principles and Techniques of Biochemistry and Molecular Biology (en inglés). Cambridge University Press. pp. 581–624. ISBN 9780511841477. doi:10.1017/cbo9780511841477.016. Consultado o 2018-11-01.

Konc J, Janežič D (abril de 2014). "Binding site comparison for function prediction and pharmaceutical discovery". Current Opinion in Structural Biology 25: 34–9. PMID 24878342. doi:10.1016/j.sbi.2013.11.012.

Fuqua C, White D (2004). Prokaryotic Intercellular Signalling. Cell Signalling in Prokaryotes and Lower Metazoa (Springer Netherlands). pp. 27–71. ISBN 9789048164837. doi:10.1007/978-94-017-0998-9_2.

Abrusan G, Marsh JA (2019). "Ligand Binding Site Structure Shapes Folding, Assembly and Degradation of Homomeric Protein Complexes.". Journal of Molecular Biology 431 (19): 3871–3888. PMC 6739599. PMID 31306664. doi:10.1016/j.jmb.2019.07.014.

Abrusan G, Marsh JA (2018). "Ligand Binding Site Structure Influences the Evolution of Protein Complex Function and Topology.". Cell Reports 22 (12): 3265–3276. PMC 5873459. PMID 29562182. doi:10.1016/j.celrep.2018.02.085.

Abrusan G, Marsh JA (2019). "Ligand-Binding-Site Structure Shapes Allosteric Signal Transduction and the Evolution of Allostery in Protein Complexes.". Molecular Biology and Evolution 36 (8): 1711–1727. PMC 6657754. PMID 31004156. doi:10.1093/molbev/msz093.

Cimermancic P, Weinkam P, Rettenmaier TJ, Bichmann L, Keedy DA, Woldeyes RA, et al. (febreiro de 2016). "CryptoSite: Expanding the Druggable Proteome by Characterization and Prediction of Cryptic Binding Sites". Journal of Molecular Biology 428 (4): 709–719. PMC 4794384. PMID 26854760. doi:10.1016/j.jmb.2016.01.029.

Beglov D, Hall DR, Wakefield AE, Luo L, Allen KN, Kozakov D, et al. (abril de 2018). "Exploring the structural origins of cryptic sites on proteins". Proceedings of the National Academy of Sciences of the United States of America 115 (15): E3416–E3425. PMC 5899430. PMID 29581267. doi:10.1073/pnas.1711490115.

Bowman GR, Bolin ER, Hart KM, Maguire BC, Marqusee S (marzo de 2015). "Discovery of multiple hidden allosteric sites by combining Markov state models and experiments". Proceedings of the National Academy of Sciences of the United States of America 112 (9): 2734–9. Bibcode:2015PNAS..112.2734B. PMC 4352775. PMID 25730859. doi:10.1073/pnas.1417811112.

Iida S, Nakamura HK, Mashimo T, Fukunishi Y (novembro de 2020). "Structural Fluctuations of Aromatic Residues in an Apo-Form Reveal Cryptic Binding Sites: Implications for Fragment-Based Drug Design". The Journal of Physical Chemistry B 124 (45): 9977–9986. PMID 33140952. doi:10.1021/acs.jpcb.0c04963.

Ahern K (xaneiro de 2017). "Teaching biochemistry online at Oregon State University". Biochemistry and Molecular Biology Education 45 (1): 25–30. PMID 27228905. doi:10.1002/bmb.20979.

Anne A, Demaille C (outubro de 2012). "Kinetics of enzyme action on surface-attached substrates: a practical guide to progress curve analysis in any kinetic situation". Langmuir 28 (41): 14665–71. PMID 22978617. doi:10.1021/la3030827.

Peng J, Li XP (novembro de 2018). "Apolipoprotein A-IV: A potential therapeutic target for atherosclerosis". Prostaglandins & Other Lipid Mediators 139: 87–92. PMID 30352313. doi:10.1016/j.prostaglandins.2018.10.004.

McNamara JW, Sadayappan S (decembro de 2018). "Skeletal myosin binding protein-C: An increasingly important regulator of striated muscle physiology". Archives of Biochemistry and Biophysics 660: 121–128. PMC 6289839. PMID 30339776. doi:10.1016/j.abb.2018.10.007.

Widemann BC, Adamson PC (xuño de 2006). "Understanding and managing methotrexate nephrotoxicity". The Oncologist 11 (6): 694–703. PMID 16794248. doi:10.1634/theoncologist.11-6-694.

Rajagopalan PT, Zhang Z, McCourt L, Dwyer M, Benkovic SJ, Hammes GG (outubro de 2002). "Interaction of dihydrofolate reductase with methotrexate: ensemble and single-molecule kinetics". Proceedings of the National Academy of Sciences of the United States of America 99 (21): 13481–6. Bibcode:2002PNAS...9913481R. PMC 129699. PMID 12359872. doi:10.1073/pnas.172501499.

Frishman WH, Cheng-Lai A, Chen J, eds. (2000). Current Cardiovascular Drugs. ISBN 978-1-57340-135-7. doi:10.1007/978-1-4615-6767-7.

Montecucco C, Molgó J (xuño de 2005). "Botulinal neurotoxins: revival of an old killer". Current Opinion in Pharmacology 5 (3): 274–9. PMID 15907915. doi:10.1016/j.coph.2004.12.006.

Roche DB, Brackenridge DA, McGuffin LJ (decembro de 2015). "Proteins and Their Interacting Partners: An Introduction to Protein-Ligand Binding Site Prediction Methods". International Journal of Molecular Sciences 16 (12): 29829–42. PMC 4691145. PMID 26694353. doi:10.3390/ijms161226202.

Broomhead NK, Soliman ME (marzo de 2017). "Can We Rely on Computational Predictions To Correctly Identify Ligand Binding Sites on Novel Protein Drug Targets? Assessment of Binding Site Prediction Methods and a Protocol for Validation of Predicted Binding Sites". Cell Biochemistry and Biophysics 75 (1): 15–23. PMID 27796788. doi:10.1007/s12013-016-0769-y.

Jones S, Thornton JM (setembro de 1997). "Analysis of protein-protein interaction sites using surface patches". Journal of Molecular Biology 272 (1): 121–32. PMID 9299342. doi:10.1006/jmbi.1997.1234.

nih.gov

ncbi.nlm.nih.gov

Ahern K (xaneiro de 2017). "Teaching biochemistry online at Oregon State University". Biochemistry and Molecular Biology Education 45 (1): 25–30. PMID 27228905. doi:10.1002/bmb.20979.

Widemann BC, Adamson PC (xuño de 2006). "Understanding and managing methotrexate nephrotoxicity". The Oncologist 11 (6): 694–703. PMID 16794248. doi:10.1634/theoncologist.11-6-694.

Montecucco C, Molgó J (xuño de 2005). "Botulinal neurotoxins: revival of an old killer". Current Opinion in Pharmacology 5 (3): 274–9. PMID 15907915. doi:10.1016/j.coph.2004.12.006.

meshb.nlm.nih.gov

"Binding site". Medical Subject Headings (MeSH). U.S. National Library of Medicine. As partes dunha molécula que participan directamente na súa combinación específica con outra molécula.

"Ligands". Medical Subject Headings (MeSH). U.S. National Library of Medicine. unha molécula que se une a outra molécula, usado especificamente para referirse a unha pequena molécula que se une especificamente a unha molécula máis grande.

worldcat.org

Dobson JA, Gerrard AJ, Pratt JA (2008). Foundations of chemical biology. Oxford University Press. ISBN 9780199248995. OCLC 487962823.

Creighton TE (2010). The Biophysical Chemistry of Nucleic Acids & Proteins. Helvetian Press. ISBN 978-0956478115. OCLC 760830351.

Morris JR, Hartl DL, Knoll AH (19 de novembro de 2015). Biology: how life works (Second ed.). Nova York, NY. ISBN 9781464126093. OCLC 937824456.

Sitio de unión (Galician Wikipedia)

archive.org